0001225208-14-006521.txt : 20140226 0001225208-14-006521.hdr.sgml : 20140226 20140226205351 ACCESSION NUMBER: 0001225208-14-006521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140224 FILED AS OF DATE: 20140226 DATE AS OF CHANGE: 20140226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 508-650-8000 MAIL ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bose Supratim CENTRAL INDEX KEY: 0001538431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 14646502 MAIL ADDRESS: STREET 1: 11A COOLING CLOSE CITY: SINGAPORE STATE: U0 ZIP: 558176 4 1 doc4.xml X0306 4 2014-02-24 0000885725 BOSTON SCIENTIFIC CORP BSX 0001538431 Bose Supratim ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 EVP & President, Asia-Pacific Deferred Stock Units 2014-02-24 4 A 0 13379.0000 0.0000 A 2019-02-24 Common Stock 13379.0000 13379.0000 D Performance Share Units 2014-02-24 4 A 0 34302.0000 0.0000 A 2015-12-31 2015-12-31 Common Stock 34302.0000 34302.0000 D Stock Option (Right to Buy) 13.0800 2014-02-24 4 A 0 31876.0000 0.0000 A 2024-02-24 Common Stock 31876.0000 31876.0000 D Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2013 adjusted free cash flow measured against its 2013 financial plan over the one-year performance period ending December 31, 2013 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2015 upon the completion of the individual service period. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. bosepoa.txt /s/ Lee G. Giguere, Attorney-in-Fact 2014-02-26 EX-24 2 bosepoa.txt POWER OF ATTORNEY Know all by these present that the undersigned hereby constitutes and appoints each of Timothy A. Pratt, Vance R. Brown, Theresa R. Boni, Scott G. Hodgdon and Lee G. Giguere signing singly, the undersigned's true and lawful attorney-in-fact to: (1) prepare and execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC; (2) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5, and amendments thereto, in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and file such form with the SEC and any stock exchange or similar authority; (4) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of the Company, Forms 144 in accordance with Rule 144 of the Securities Act of 1933, as amended, and the rules and regulations thereunder; and (5) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended, or Rule 144 of the Securities Act of 1933, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 28th day of January, 2014. /s/ Supratim Bose ____________________ Supratim Bose